國新健康(000503.SZ):擬2460萬元收購壹永科技5.05%股權並向其增資5740萬元
格隆匯7月20日丨國新健康(000503.SZ)公佈,公司擬與北京壹永科技有限公司(“壹永科技”或“標的公司”)及其投資人共同簽署《北京壹永科技有限公司之股權轉讓及增資認購協議》,公司擬以現金方式購買武漢盛世絡微企業管理諮詢合夥企業(有限合夥)(“盛世絡微”)持有的壹永科技5.05%股權,交易價格為人民幣2460萬元。
上述轉讓完成後,公司擬以現金方式出資人民幣5740萬元對標的公司進行增資,增資完成後國新健康對標的公司持股比例將達到10.02%。
壹永科技成立於2017年10月,是一家圍繞腫瘤大數據生態體系開展業務的科技企業,標的公司協助國家相關單位建設了腫瘤大數據庫,在建設過程中積累了腫瘤數據收集、質控、治理的數據處理能力,併為腫瘤大數據分析與挖掘提供技術支持。壹永科技不斷探索商業路徑,將中心端業務向醫院端業務進行延伸,研發形成數據治理平台、臨牀科研一體化平台、醫院端的單病種質控平台等院端產品,未來計劃為腫瘤患者提供綜合服務,滿足腫瘤患者疾病診療中的實際需求。
基於未來商業化的院端業務模式展望,以及國新健康與標的公司在數據、平台、資源等方面的互補性考慮,交易完成後,雙方整體資源運轉效率會有所提高,核心競爭力將得到有效利用和拓展,對公司財務狀況或將產生積極影響,符合公司的未來發展方向和戰略定位。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.